Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Reflections: neurology and the humanities. Whose side are you on?

Brooke MH.

Neurology. 2007 Dec 11;69(24):2269-71. No abstract available.

PMID:
18071148
2.

What's the use?

Brooke MH.

Neurology. 2006 May 9;66(9):1453-4. No abstract available.

PMID:
16682689
3.

Natural selection.

Brooke MH.

Neurology. 2006 Jan 24;66(2):290-2. No abstract available.

PMID:
16434683
4.

Fiction: human errors.

Brooke MH.

Neurology. 2005 Sep 13;65(5):779-80. No abstract available.

PMID:
16157926
5.

Fiction: no laughing matter.

Brooke MH.

Neurology. 2005 Jun 14;64(11):1986-8. No abstract available.

PMID:
15955967
6.

Fiction: the Christmas card.

Brooke MH.

Neurology. 2005 Mar 8;64(5):929-30. No abstract available.

PMID:
15753449
7.

Fiction: lemon, with a twist.

Brooke MH.

Neurology. 2003 Dec 23;61(12):1824-5. No abstract available.

PMID:
14694065
8.

The Websters' dictionary: the binification of medical and neurologic education.

Brooke MH.

Neurology. 2000 Apr 25;54(8):1554-6. No abstract available.

PMID:
10762492
9.

The Webster's dictionary: neurologists on the Internet.

Beresford HR, Brooke MH.

Neurology. 1999 Jun 10;52(9):1730-1. No abstract available.

PMID:
10371514
10.

The electronic journal: sophisters, economists, and calculators.

Brooke MH.

Neurology. 1999 Jan 1;52(1):4-6. No abstract available.

PMID:
9921837
11.

Neurotrophic factors decrease the release of creatine kinase and prostaglandin E2 from metabolically stressed muscle.

Lian JD, al-Jumah M, Cwik V, Brooke MH.

Neuromuscul Disord. 1998 Feb;8(1):7-13.

PMID:
9565985
12.

Advances in ALS workshop summary: Research and future goals.

Brooke MH, Strong MJ.

Neurology. 1996 Oct;47(4 Suppl 2):S108-12. No abstract available.

PMID:
8858063
13.

Diagnostic criteria in clinical trials.

Brooke MH.

Neurology. 1996 Oct;47(4 Suppl 2):S67-9; discussion S70. Review. No abstract available.

PMID:
8858054
14.

Evidence of a temperature-sensitive step in the release of prostaglandin E2 in calcium ionophore-stimulated rat muscle.

Majumdar R, Gowda D, Brooke MH.

Prostaglandins Leukot Essent Fatty Acids. 1995 Aug;53(2):117-22.

PMID:
7480073
15.
16.

Effects of calcium channel antagonists on the release of prostaglandin E2 from metabolically stressed muscle.

Majumdar R, Nguyen JT, Brooke MH.

Biochem Pharmacol. 1994 Jul 19;48(2):371-4.

PMID:
8053933
17.
18.

Relationship of oxypurine release to contractile failure in dinitrophenol-treated rat skeletal muscle.

Majumdar R, Cwik VA, Solonynko G, Brooke MH.

Acta Physiol Scand. 1993 Nov;149(3):249-55.

PMID:
8310832
19.

Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy.

Kissel JT, Lynn DJ, Rammohan KW, Klein JP, Griggs RC, Moxley RT 3rd, Cwik VA, Brooke MH, Mendell JR.

Neurology. 1993 Mar;43(3 Pt 1):532-6.

PMID:
8450996
20.

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

Griggs RC, Moxley RT 3rd, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP, Cwik VA, Pandya S, Robison J, et al.

Neurology. 1993 Mar;43(3 Pt 1):520-7.

PMID:
8450994
21.

ATPase stain in muscle histochemistry.

Pestronk GJ, Kaiser KK, Brooke MH.

Muscle Nerve. 1992 Feb;15(2):258. No abstract available.

PMID:
1372392
22.

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.

Fenichel GM, Florence JM, Pestronk A, Mendell JR, Moxley RT 3rd, Griggs RC, Brooke MH, Miller JP, Robison J, King W, et al.

Neurology. 1991 Dec;41(12):1874-7.

PMID:
1745340
23.

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy.

Fenichel GM, Mendell JR, Moxley RT 3rd, Griggs RC, Brooke MH, Miller JP, Pestronk A, Robison J, King W, Signore L, et al.

Arch Neurol. 1991 Jun;48(6):575-9.

PMID:
2039377
24.

Glutathione depletion during experimental damage to rat skeletal muscle and its relevance to Duchenne muscular dystrophy.

Jackson MJ, Brooke MH, Kaiser K, Edwards RH.

Clin Sci (Lond). 1991 Jun;80(6):559-64.

PMID:
1647917
25.

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group.

Griggs RC, Moxley RT 3rd, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP.

Arch Neurol. 1991 Apr;48(4):383-8.

PMID:
2012511
26.

Creatine kinase and prostaglandin E2 release from isolated Duchenne muscle.

Jackson MJ, Brooke MH, Kaiser K, Edwards RH.

Neurology. 1991 Jan;41(1):101-4.

PMID:
1845917
27.

Randomized, double-blind trial of mazindol in Duchenne dystrophy.

Griggs RC, Moxley RT 3rd, Mendell JR, Fenichel GM, Brooke MH, Miller PJ, Mandel S, Florence J, Schierbecker J, Kaiser KK, et al.

Muscle Nerve. 1990 Dec;13(12):1169-73.

PMID:
2266990
28.

Issues in myoblast transfer.

Brooke MH.

Adv Exp Med Biol. 1990;280:231-3. Review. No abstract available.

PMID:
2248143
29.

Introductory comments on disease-specific tests.

Brooke MH.

Muscle Nerve. 1990;13 Suppl:S38-9. No abstract available.

PMID:
2233883
30.

Fatigue testing.

Brooke MH, Miller R.

Muscle Nerve. 1990;13 Suppl:S35-7. No abstract available.

PMID:
2233882
31.

Testing of therapeutic interventions in humans.

Fenichel GM, Cooper DO, Brooke MH.

Muscle Nerve. 1990;13 Suppl:S1. No abstract available.

PMID:
2233873
32.

Two dissimilar brothers with Becker's dystrophy have an identical genetic defect.

Medori R, Brooke MH, Waterston RH.

Neurology. 1989 Nov;39(11):1493-6.

PMID:
2682349
33.

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.

Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J, et al.

N Engl J Med. 1989 Jun 15;320(24):1592-7.

PMID:
2657428
34.

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J, King WM, Pandya S, Robison J, Schierbecker J, et al.

Neurology. 1989 Apr;39(4):475-81.

PMID:
2927672
35.

Genetic abnormalities in Duchenne and Becker dystrophies: clinical correlations.

Medori R, Brooke MH, Waterston RH.

Neurology. 1989 Apr;39(4):461-5.

PMID:
2648185
36.

Randomized controlled trial of testosterone in myotonic dystrophy.

Griggs RC, Pandya S, Florence JM, Brooke MH, Kingston W, Miller JP, Chutkow J, Herr BE, Moxley RT 3rd.

Neurology. 1989 Feb;39(2 Pt 1):219-22.

PMID:
2521699
37.
38.

Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.

Fenichel GM, Brooke MH, Griggs RC, Mendell JR, Miller JP, Moxley RT 3rd, Park JH, Provine MA, Florence J, Kaiser KK, et al.

Muscle Nerve. 1988 Nov;11(11):1164-8.

PMID:
3067086
39.

2,4-Dinitrophenol, muscle biopsy, and McArdle's disease.

Heller SL, Brooke MH, Kaiser KK, Choski R.

Neurology. 1988 Jan;38(1):15-9.

PMID:
3422109
40.

Genetic heterogeneity in Duchenne dystrophy.

Hyser CL, Province M, Griggs RC, Mendell JR, Fenichel GM, Brooke MH, Miller JP, Polakowska R, Doherty RA, Quirk S, et al.

Ann Neurol. 1987 Oct;22(4):553-5.

PMID:
3435074
41.

Carrier assessment for mothers and sisters of isolated Duchenne dystrophy cases: the importance of serum enzyme determinations.

Hyser CL, Doherty RA, Griggs RC, Mendell JR, Polakowska R, Quirk S, Brooke MH, Fenichel GM.

Neurology. 1987 Sep;37(9):1476-80.

PMID:
2888052
42.

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley RT 3rd, Miller JP, Kaiser KK, Florence JM, Pandya S, Signore L, et al.

Arch Neurol. 1987 Aug;44(8):812-7.

PMID:
3632393
43.

Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls.

Mendell JR, Province MA, Moxley RT 3rd, Griggs RC, Brooke MH, Fenichel GM, Miller JP, Kaiser KK, King W, Robison J, et al.

Arch Neurol. 1987 Aug;44(8):808-11.

PMID:
3115236
44.

McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.

Heller SL, Kaiser KK, Planer GJ, Hagberg JM, Brooke MH.

Neurology. 1987 Jun;37(6):1039-42.

PMID:
3473311
45.

Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipine.

Moxley RT 3rd, Brooke MH, Fenichel GM, Mendell JR, Griggs RC, Miller JP, Province MA, Patterson V.

Muscle Nerve. 1987 Jan;10(1):22-33.

PMID:
3550455
46.

Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.

Hyser CL, Griggs RC, Mendell JR, Polakowska R, Quirk S, Brooke MH, Fenichel GM, Doherty RA.

Neurology. 1987 Jan;37(1):4-10.

PMID:
2879259
47.

IMP response: an indicator of metabolic stress in working muscle.

Heller SL, Choksi R, Brooke MH.

Muscle Nerve. 1986 Jul-Aug;9(6):515-8.

PMID:
3736584
48.

'Dystrophic' lipid myopathy in two sisters.

Carroll JE, Brooke MH, Villadiego A, Norris BJ, Trefz JI.

Arch Neurol. 1986 Feb;43(2):128-31.

PMID:
3947249
49.

Inosine monophosphate production is proportional to muscle force in vitro.

Brooke MH, Choksi R, Kaiser KK.

Neurology. 1986 Feb;36(2):288-91.

PMID:
3945403
50.

Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.

Brooke MH, Florence JM, Heller SL, Kaiser KK, Phillips D, Gruber A, Babcock D, Miller JP.

Neurology. 1986 Feb;36(2):146-51.

PMID:
3080694

Supplemental Content

Loading ...
Support Center